Compugen Ltd. (CGEN)
2.13
+0.01
(+0.47%)
USD |
NASDAQ |
Oct 09, 16:00
2.13
0.00 (0.00%)
After-Hours: 20:00
Compugen Net Income (Quarterly) : -7.006M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.006M |
| March 31, 2026 | -7.669M |
| December 31, 2025 | 56.84M |
| September 30, 2025 | -6.979M |
| June 30, 2025 | -7.342M |
| March 31, 2025 | -7.181M |
| December 31, 2024 | -6.117M |
| September 30, 2024 | 1.276M |
| June 30, 2024 | -2.123M |
| March 31, 2024 | -7.267M |
| December 31, 2023 | 9.713M |
| September 30, 2023 | -9.852M |
| June 30, 2023 | -9.276M |
| March 31, 2023 | -9.339M |
| December 31, 2022 | -3.092M |
| September 30, 2022 | -11.75M |
| June 30, 2022 | -9.144M |
| March 31, 2022 | -9.71M |
| December 31, 2021 | -8.645M |
| September 30, 2021 | -6.156M |
| June 30, 2021 | -9.497M |
| March 31, 2021 | -9.905M |
| December 31, 2020 | -8.563M |
| September 30, 2020 | -7.761M |
| June 30, 2020 | -6.246M |
| Date | Value |
|---|---|
| March 31, 2020 | -7.128M |
| December 31, 2019 | -6.461M |
| September 30, 2019 | -6.491M |
| June 30, 2019 | -5.977M |
| March 31, 2019 | -8.408M |
| December 31, 2018 | -9.399M |
| September 30, 2018 | -3.111M |
| June 30, 2018 | -10.19M |
| March 31, 2018 | 0.104M |
| December 31, 2017 | -9.31M |
| September 30, 2017 | -9.871M |
| June 30, 2017 | -9.178M |
| March 31, 2017 | -8.707M |
| December 31, 2016 | -8.492M |
| September 30, 2016 | -7.781M |
| June 30, 2016 | -6.632M |
| March 31, 2016 | -8.601M |
| December 31, 2015 | -0.472M |
| September 30, 2015 | -6.742M |
| June 30, 2015 | -6.808M |
| March 31, 2015 | -6.143M |
| December 31, 2014 | -1.482M |
| September 30, 2014 | -5.395M |
| June 30, 2014 | -2.319M |
| March 31, 2014 | -1.898M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Pluri, Inc. | -6.193M |
| Evogene Ltd. | -1.591M |
| Scinai Immunotherapeutics Ltd. | -2.037M |
| CollPlant Biotechnologies Ltd. | -2.726M |
| Regentis Biomaterials Ltd. | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.602M |
| Total Expenses (Quarterly) | 9.608M |
| EPS Diluted (Quarterly) | -0.074 |
| Enterprise Value | 79.49M |
| Gross Profit Margin (Quarterly) | -3.54% |
| Profit Margin (Quarterly) | -269.3% |
| Earnings Yield | 17.39% |
| Operating Earnings Yield | 15.07% |
| Normalized Earnings Yield | 17.39 |